Publication du groupe

Chloé Bianchi, Henri Margot, Helder Fernandes et al. Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patient.Br. J. Hematol 2024 Mar 3. doi: 10.1111/bjh.19387. (PUBMED – Site de la revue)

Jérome Granel, Helder Fernandes, Brigitte Bader-Meunier et al. Antinuclear antibodies associated auto-immune cytopenia in childhood is a risk factor for systemic lupus erythematosus. Blood 2024 Jan 16:blood.2023021884. (PUBMED – Site de la revue)

M. Gilton, H. Fernandes, C Martinez et al. Association of paediatric autoimmune cytopenia and inflammatory bowel disease suggests a common genetic origin. Br J Haematol. 2024 Oct;205(4):1508-1515. doi: 10.1111/bjh.19701. Epub 2024 Aug 18 (PUBMED – Site de la revue)

Thomas Pincez, Helder Fernandes, Mony Fahd et al. Pediatric refractory chronic immune thrombocytopenia: Identification, patients’ characteristics, and outcome. Am J Hematol . 2024 Jul;99(7):1269-1280. doi: 10.1002/ajh.27337. Epub 2024 Apr 23. (PUBMED – Site de la revue)

Mahlaoui N, Fouyssac F, Mazingue F, Mallebranche C, Barthez-Toullec M, Denti L, et al. Real-world experience with CLAIRYG® 50 mg/mL (intravenous immunoglobulin) in children under 12 years with primary immunodeficiency or immmune thrombocytopenia: a post-approval safety study. Front Pediatr. 2023;11:1260296. (PUBMED – Site de la revue)

Aladjidi N, Pincez T, Rieux-Laucat F, Nugent D. Paediatric-onset Evans syndrome: Breaking away from refractory immune thrombocytopenia. Br J Haematol. oct 2023;203(1):28‑35. (PUBMED – Site de la revue)

Schifferli A, Le Gavrian G, Aladjidi N, Moulis G, Godeau B, Kühne T. Chronic refractory immune thrombocytopenia in adolescents and young adults. Br J Haematol. oct 2023;203(1):36‑42. (PUBMED – Site de la revue)

Moulis G, Aladjidi N, Godeau B. Clinical significance of antinuclear antibodies in primary immune thrombocytopenia. Br J Haematol. oct 2023;203(1):131‑5. (PUBMED – Site de la revue)

Pincez T, Fernandes H, Pasquet M, et al. Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia. Am J Hematol. Published online March 7, 2023. (PUBMED – Site de la revue)

Pincez T, Fernandes H, Leblanc T, Michel G, Barlogis V, Bertrand Y, et al. Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden. Haematologica. 2022 (PUBMED – Site de la revue)

Dhunputh C, Ducassou S, Fernandes H, Picard C, Rieux-Laucat F, Viallard J-F, et al. Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects. Blood. 2022 (PUBMED – Site de la revue)

Pincez T, Aladjidi N, Heritier S, Garnier N, Fahd M, Abou Chahla W, et al. Determinants of splenectomy long-term outcomes in pediatric autoimmune cytopenias. Blood. 2022 (PUBMED – Site de la revue)

Ducassou S, Fernandes H, Savel H, Bertrand Y, Leblanc T, Abou Chahla W, et al. Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation. J Pediatr. 2021(PUBMED – Site de la revue)

Nolla M, Aladjidi N, Leblanc TM, Fernandes H, Ducassou S, Fahd M, et al. Thrombopoietin receptor agonists as an emergency treatment of severe newly diagnosed immune thrombocytopenia in children.  Blood. 2021. (PUBMED – Site de la revue)

Margot H, Boursier G, Duflos C, Sanchez E, Amiel J, Andrau J-C, et al. Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals. Genet Med Off J Am Coll Med Genet. 2020 (PUBMED – Site de la revue)

Ducassou S, Gourdonneau A, Fernandes H, Leverger G, Pasquet M, Fouyssac F, et al. Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years. Br J Haematol. 2020 (PUBMED – Site de la revue)

Hadjadj J, Castro CN, Tusseau M, Stolzenberg M-C, Mazerolles F, Aladjidi N, et al. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat Commun 2020 (PUBMED – Site de la revue)

Marxgut M, Adjaoud D, Aladjidi N, Armari C, Marxgut L, Rubio A. Generalized Verrucosis Revealing a Life-Threatening and Unlabeled T-Cell Lymphopenia Associated With Autoimmune Hemolytic Anemia: A Case Report and Review of Literature. J Pediatr Hematol Oncol. 2020 (PUBMED – Site de la revue)

Pincez T, Neven B, Le Pointe HD, Varlet P, Fernandes H, Gareton A et al., Neurological Involvement in Childhood Evans Syndrome. J Clin Immunol 2019 (PUBMED – Site de la revue)

Hadjadj J, Aladjidi N, Fernandes H, Leverger G, Magérus-Chatinet A, Mazerolles F et al., Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood 2019 (PUBMED – Site de la revue)

Besnard C, Levy E, Aladjidi N, Stolzenberg MC, Magerus-Chatinet A, Alibeu O, et al. Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations. Clinical immunology. 2018. (PUBMED – Site de la revue)

Penel Page M, Bertrand Y, Fernandes H, Kherfellah D, Leverger G, Leblanc T et al. Treatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS’CEREVANCE Am J Hematol 2018 (PUBMED – Site de la revue)

Roche O, Aladjidi N, Rakotonjanahary J, Leverger G, Leblanc T, Thomas C, et al. Evaluation of the efficiency of hydroxychloroquine in treating children with immune thrombocytopenia (ITP). American journal of hematology. 2017.(PUBMED – Site de la revue)

Ducassou S, Leverger G, Fernandes H, Chambost H, Bertrand Y, Armari-Alla C, et al. Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study Br J Haematol. 2017.(PUBMED – Site de la revue)

Aladjidi N, Jutand M-A, Beaubois C, Fernandes H, Jeanpetit J, Coureau G, et al. Reliable assessment of the incidence of childhood autoimmune hemolytic anemia. Pediatric Blood Cancer. 2017 Jul 27. (PUBMED – Site de la revue)

Grimaldi-Bensouda L, Nordon C, Leblanc T, Abenhaim L, Allali S, Armari-Alla C, et al. Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes. Pediatric blood & cancer. 2016.(PUBMED – Site de la revue)

Aladjidi N, Fernandes H, Leblanc T, Vareliette A, Rieux-Laucat F, Bertrand Y, et al. Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort. Frontiers in pediatrics. 2015.(PUBMED – Site de la revue)

Pasquet M, Aladjidi N, Guitton C, Leblanc T, Perel Y, G. L. Recommandations d’utilisation des agonistes du récepteur de la thrombopoïétine dans le purpura thrombopénique immunologique de l’enfant et de l’adolescent. Rev Onc Hematol Pedia. 2015;3(1).(Site de la revue)

Pasquet M, Aladjidi N, Guiton C, Courcoux MF, Munzer M, Auvrignon A, et al. Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience. Br J Haematol. 2014.(PUBMED – Site de la revue)

Aladjidi N, Santiago R, Pondarre C, Lambilliotte A, Leverger G, Godard Sebillotte C, et al. Revisiting Splenectomy in Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies: The French Experience. J Blood Disord Transfus. 2012;S3:003.(Site de la revue)

Aladjidi N, Leverger G, Leblanc T, Picat MQ, Michel G, Bertrand Y, et al. New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica. 2011;96(5):655-63.(PUBMED – Site de la revue)

Fresneau B, Petit A, Courcoux MF, Tabone MD, Auvrignon A, Landman-Parker J, et al. Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia. American journal of hematology. 2011;86(9):785-7.(PUBMED – Site de la revue)

Ducassou S, Aladjidi N, Lutz P. Rituximab in the management of chronic immune thrombocytopenic purpura: what is its place? Pediatric blood & cancer. 2010;54(4):632.(PUBMED – Site de la revue)

Bader-Meunier B, Aladjidi N, Bellmann F, Monpoux F, Nelken B, Robert A, et al. Rituximab therapy for childhood Evans syndrome. Haematologica. 2007;92(12):1691-4.(PUBMED – Site de la revue)

Lutz P, Villega F, Ducassou S, Entz-Werle N, Michel G, Societe Francaise d’Hematologie et d’Immunologie P. Management of childhood idiopathic thrombocytopenic purpura: a survey of members of the French Society of Pediatric Hematology and Immunology (SHIP). Archives de pediatrie. 2007;14(5):444-9. (PUBMED – Site de la revue)